Related Content
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...
March 14, 2018
January 21, 2015 — A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in ...
January 21, 2015
September 2, 2014 – Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...
September 02, 2014March 12, 2014 — Janssen Research and Development LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) ...
March 12, 2014January 22, 2014 — The U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted ...
January 22, 2014July 15, 2013 — Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) has issued a ...
July 15, 2013April 12, 2013 — The U.S. Food and Drug Administration (FDA) issued a second complete response letter regarding a ...
April 12, 2013
November 7, 2012 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 07, 2012
June 22, 2012 — The the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee voted ...
June 22, 2012February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has ...
February 28, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now